SureTrader SureTrader Nadex Advertisement SureTrader
Home > Boards > US Listed > Miscellaneous > Rigel Pharmaceuticals Inc. (RIGL)

7:40AM On The Wires (WIRES) :

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
surf1944 Member Profile
 
Followed By 411
Posts 22,051
Boards Moderated 2
Alias Born 09/11/06
160x600 placeholder
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/14/2017 11:55:50 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/14/2017 11:31:42 AM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 2/10/2017 12:54:42 PM
Schedule 13g "Edgar (US Regulatory)" - 2/9/2017 11:00:35 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/8/2017 4:18:26 PM
Rigel Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Option To Purchase Additional Shares "PR Newswire (US)" - 2/3/2017 4:01:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/31/2017 4:23:20 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 1/31/2017 4:20:44 PM
Rigel Announces Pricing Of Public Offering Of Common Stock "PR Newswire (US)" - 1/31/2017 7:30:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/30/2017 4:40:38 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 1/30/2017 4:15:07 PM
Rigel Announces Proposed Public Offering Of Common Stock "PR Newswire (US)" - 1/30/2017 4:01:00 PM
Fostamatinib Study Results Continue to Trend Positive "PR Newswire (US)" - 1/30/2017 7:30:00 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 1/25/2017 5:31:43 PM
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) "PR Newswire (US)" - 1/16/2017 7:30:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 1/13/2017 6:03:30 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 1/12/2017 5:20:39 PM
Rigel Provides Business Updates and Preliminary Data in IgA Nephropathy "PR Newswire (US)" - 1/5/2017 7:30:00 AM
Schedule 13g "Edgar (US Regulatory)" - 12/12/2016 11:23:13 AM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 11/18/2016 3:57:57 PM
Rigel to Present at Jefferies 2016 London Healthcare Conference "PR Newswire (US)" - 11/10/2016 7:30:00 AM
Securities Registration: Employee Benefit Plan (s-8) "Edgar (US Regulatory)" - 11/1/2016 5:07:47 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/1/2016 4:24:06 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/1/2016 4:18:00 PM
Rigel Announces Third Quarter 2016 Financial Results and Provides Company Update "PR Newswire (US)" - 11/1/2016 4:01:00 PM
surf1944   Friday, 05/06/11 09:58:11 AM
Re: surf1944 post# 130
Post # of 422 
7:40AM On The Wires (WIRES) :

Rigel Pharmaceuticals, Inc. (RIGL) announced that the company will assume development of R343, its inhaled syk inhibitor for allergic asthma that recently completed several Phase 1 clinical trials. Pfizer (PFE) is returning full rights to the R343 program as a result of its decision to exit the allergy and respiratory therapeutic area within R&D. Rigel is evaluating the details of R343's development to date and expects to design a Phase 2 clinical trial with R343 later this year.



surf's up......crikey



SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist